Meet the Scientist - August 2013

Printer-friendly versionPrinter-friendly version

Meet the Scientist Webinar Series

Please join us by phone or on the web for our Meet the Scientist Webinar Series! Hear leading mental health researchers present the latest in new technologies, diagnostic tools, early intervention strategies and next generation therapies for mental illness.

Webinar Details:

Topic: "Ketamine & Next Generation Therapies"
When: Tuesday, August 13, 2:00 p.m.–3:00 p.m. EST

View Recordings

download slideshow presentation
download slideshow presentation

 

Watch this video about Dr. Zarate's prizewinning research:

Read more about Ketamine:

Speaker:

Carlos A. Zarate, M.D.
2011 Bipolar Mood Disorder Outstanding Achievement Prize Recipient (renamed the Colvin Prize for Outstanding Achievement in Mood Disorders Research in 2012)
Chief, Section on the Neurobiology and Treatment of Mood Disorders
Chief, Experimental Therapeutics and Pathophysiology Branch
National Institute of Mental Health
Clinical Professor, Psychiatry and Behavioral Sciences
The George Washington University

Carlos A. Zarate, M.D., Expert on Ketamine and DepressionCarlos A. Zarate, M.D., a NARSAD Independent Investigator Grantee (2005), has pioneered revolutionary studies that have led to novel treatments for mood disorders such as depression and bipolar disorder that begin working much faster than previous options. With a strong focus on the pathophysiology of severe mental illnesses, his goal is to develop better treatments particularly for patients living with depression, bipolar disorder and/or other mood disorders. His research into a drug called Ketamine has resulted in rapid-acting depression treatments that work within hours and last 3-5 days or more. Because of the speed at which this drug reacts within the body and the duration of its effects, it is possible that emergency room doctors may have a possible treatment for those suffering from depression and acute suicidality.

Moderator:

Jeffrey Borenstein, M.D.
President & CEO, Brain & Behavior Research Foundation

Jeffrey Borenstein, M.D., Acting President and CEO of the Brain & Behavior Research FoundationJeffrey Borenstein, M.D., joined the Brain & Behavior Research Foundation in 2012 as Chief Medical Officer and was appointed as President & Chief Executive Officer at the start of 2013. Dr. Borenstein has more than two decades of experience in health and non-profit leadership. He is former CEO/Medical Director of Holliswood Hospital, where he served from 1996 to 2012. He is a board-certified psychiatrist and the Host of the award-winning series, “Healthy Minds,” which is broadcast on public television stations across the United States. He is Editor in Chief of Psychiatric News, the newspaper of the American Psychiatric Association.

An active contributor to the psychiatric field  for more than three decades, Dr. Borenstein currently chairs the Council on Communications of the American Psychiatric Association, the Mental Health Services Council of NY State, and the Section on Psychiatry, NY Academy of Medicine, where he is a Fellow. Among the many honors to his credit are the National Alliance on Mental Illness of NY State Connie Lieber Award, the American Psychiatric Association Special Presidential Commendation and the Federation of Organizations Community Mental Health Man of the Year Award. 

Dr. Borenstein is Associate Clinical Professor of Psychiatry, Columbia University College of Physicians & Surgeons. He is a graduate of Harvard College and New York University School of Medicine.

View schedule of other upcoming webinars at: bbrfoundation.org/webinar

For other upcoming events, visit: bbrfoundation.org/events

Download: 
http://bbrfoundation.org/sites/bbrf.civicactions.net/files/file-downloads/ketamine-zarate-final.pdf